Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Carallia brachiata

ABSTRACT: Carallia brachiata Genome sequencing

PROVIDER: PRJNA632974 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR12147466_1.fastq.gz	Fastqsanger.gz
	SRR12147466_2.fastq.gz	Fastqsanger.gz
	SRR12147467_1.fastq.gz	Fastqsanger.gz
	SRR12147467_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 72

Similar Datasets

Carallia brachiata

Project description:Carallia brachiata overview

| PRJNA772848 | ENA

Carallia brachiata

Project description:Carallia brachiata Genome sequencing and assembly

| PRJNA631329 | ENA

Salicornia brachiata

Project description:Salicornia brachiata overview

| PRJNA1205433 | ENA

Project description:WGS of Carallia brachiata

| PRJNA801906 | ENA

Salicornia brachiata isolate:Local isolate

Project description:Molecular insight into salt tolerance mechanism of Salicornia brachiata

| PRJNA1050854 | ENA

GNPS_Isolated of fungus C brachiata jk15+

Project description:This work aims to isolate compounds of the fungus C brachiata

| MSV000082893 | GNPS

Project description:Salicornia brachiata genome sequencing and assembly

| PRJNA732071 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Development of microsatellite markers for Carallia brachiata (Rhizophoraceae).

Project description:Microsatellite markers were developed for Carallia brachiata to assess the genetic diversity and structure of this terrestrial species of the Rhizophoraceae. Based on transcriptome data for C. brachiata, 40 primer pairs were initially designed and tested, of which 18 were successfully amplified and 11 were polymorphic. For these microsatellites, one to three alleles per locus were identified. The observed and expected heterozygosities ranged from 0 to 0.727 and 0 to 0.520, respectively. In addition, all primers were successfully amplified in two congeners: C. pectinifolia and C. garciniifolia. The microsatellite markers described here will be useful in population genetic studies of C. brachiata and related species, suggesting that developing microsatellite markers from next-generation sequencing data can be efficient for genetic studies across this genus.

| S-EPMC4356322 | biostudies-literature

eoAcrBrac

Project description:Acrocnida brachiata (sand burrowing brittlestar)

| PRJEB80827 | ENA